211 related articles for article (PubMed ID: 11937598)
1. Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.
Watanabe K; Takahashi T; Nakazawa M; Wahed MI; Fuse K; Tanabe N; Kodama M; Aizawa Y; Ashino H; Tazawa S
J Nucl Med; 2002 Apr; 43(4):531-5. PubMed ID: 11937598
[TBL] [Abstract][Full Text] [Related]
2. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy.
Watanabe K; Ohta Y; Nakazawa M; Higuchi H; Hasegawa G; Naito M; Fuse K; Ito M; Hirono S; Tanabe N; Hanawa H; Kato K; Kodama M; Aizawa Y
Br J Pharmacol; 2000 Aug; 130(7):1489-95. PubMed ID: 10928949
[TBL] [Abstract][Full Text] [Related]
3. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
Maunoury C; Acar P; Sidi D
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
[TBL] [Abstract][Full Text] [Related]
5. Myocardial adrenergic dysinnervation in dilated cardiomyopathy: cornerstone or epiphenomenon?
Merlet P; Hittinger L; Dubois-Randé JL; Castaigne A
J Nucl Med; 2002 Apr; 43(4):536-9. PubMed ID: 11937599
[No Abstract] [Full Text] [Related]
6. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
[TBL] [Abstract][Full Text] [Related]
7. Use of thallium-201 myocardial scintigraphy for the prediction of the response to beta-blocker therapy in patients with dilated cardiomyopathy.
Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Nakata S; Shigematsu Y
Circ J; 2002 Dec; 66(12):1139-43. PubMed ID: 12499621
[TBL] [Abstract][Full Text] [Related]
8. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
Chizzola PR; Gonçalves de Freitas HF; Marinho NV; Mansur JA; Meneghetti JC; Bocchi EA
Int J Cardiol; 2006 Jan; 106(1):29-34. PubMed ID: 16321662
[TBL] [Abstract][Full Text] [Related]
9. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
10. Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
Lotze U; Kaepplinger S; Kober A; Richartz BM; Gottschild D; Figulla HR
J Nucl Med; 2001 Jan; 42(1):49-54. PubMed ID: 11197980
[TBL] [Abstract][Full Text] [Related]
11. The effect of beta-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy.
Inoue A; Yamashina S; Yamazaki J
Ann Nucl Med; 2003 Dec; 17(8):677-83. PubMed ID: 14971610
[TBL] [Abstract][Full Text] [Related]
12. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
[TBL] [Abstract][Full Text] [Related]
13. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
Nikolaidis LA; Poornima I; Parikh P; Magovern M; Shen YT; Shannon RP
J Am Coll Cardiol; 2006 May; 47(9):1871-81. PubMed ID: 16682315
[TBL] [Abstract][Full Text] [Related]
14. Effects of short-term carvedilol on the cardiac sympathetic activity assessed by 123I-MIBG scintigraphy.
Miranda SM; Mesquita ET; Dohmann HF; Azevedo JC; Barbirato GB; Freire Fde L; Ribeiro ML; Nóbrega AC; Coimbra A; Mesquita CT
Arq Bras Cardiol; 2010 Mar; 94(3):308-12, 328-32. PubMed ID: 20730258
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis.
Liu H; Li W; Gu W; Kong Y; Yang N; Chen L
Scand J Immunol; 2010 Jan; 71(1):38-44. PubMed ID: 20017808
[TBL] [Abstract][Full Text] [Related]
16. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy.
Fujimura M; Yasumura Y; Ishida Y; Nakatani S; Komamura K; Yamagishi M; Miyatake K
J Card Fail; 2000 Mar; 6(1):3-10. PubMed ID: 10746813
[TBL] [Abstract][Full Text] [Related]
17. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.
Merlet P; Pouillart F; Dubois-Randé JL; Delahaye N; Fumey R; Castaigne A; Syrota A
J Nucl Med; 1999 Feb; 40(2):224-31. PubMed ID: 10025827
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.
Yoshikawa E; Marui A; Tsukashita M; Nishina T; Wang J; Muranaka H; Ikeda T; Komeda M
Eur J Cardiothorac Surg; 2010 Feb; 37(2):362-7. PubMed ID: 19692266
[TBL] [Abstract][Full Text] [Related]
19. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
Kurum T; Tatli E; Yuksel M
Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
[TBL] [Abstract][Full Text] [Related]
20. Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis.
Juan W; Nakazawa M; Watanabe K; Ma M; Wahed MI; Hasegawa G; Naito M; Yamamoto T; Fuse K; Kato K; Kodama M; Aizawa Y
Mol Cell Biochem; 2003 Sep; 251(1-2):77-82. PubMed ID: 14575307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
